Full text
PDFPage 694
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Goldman J. A., Fishman A. B., Lee J. E., Johnson R. J. The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Arthritis Rheum. 1989 Mar;32(3):358–359. doi: 10.1002/anr.1780320324. [DOI] [PubMed] [Google Scholar]
- Khattak F. H., Morris I. M., Branford W. A. Simvastatin-associated dermatomyositis. Br J Rheumatol. 1994 Feb;33(2):199–199. doi: 10.1093/rheumatology/33.2.199. [DOI] [PubMed] [Google Scholar]
- Norman D. J., Illingworth D. R., Munson J., Hosenpud J. Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin. N Engl J Med. 1988 Jan 7;318(1):46–47. doi: 10.1056/NEJM198801073180110. [DOI] [PubMed] [Google Scholar]
- Schalke B. B., Schmidt B., Toyka K., Hartung H. P. Pravastatin-associated inflammatory myopathy. N Engl J Med. 1992 Aug 27;327(9):649–650. doi: 10.1056/nejm199208273270919. [DOI] [PubMed] [Google Scholar]
- Wallace C. S., Mueller B. A. Lovastatin-induced rhabdomyolysis in the absence of concomitant drugs. Ann Pharmacother. 1992 Feb;26(2):190–192. doi: 10.1177/106002809202600209. [DOI] [PubMed] [Google Scholar]
- Zuckner J. Drug-related myopathies. Rheum Dis Clin North Am. 1994 Nov;20(4):1017–1032. [PubMed] [Google Scholar]